Vanda Pharmaceuticals reported $507.11M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 521.55M 10.97M
Agios Pharmaceuticals AGIO:US USD 784.94M 85.07M
Akebia Therapeutics AKBA:US USD 237.51M 66.65M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 219.21M
Anika Therapeutics ANIK:US USD 167.76M 95K
Arrowhead Research ARWR:US USD 405.3M 27.09M
AstraZeneca AZN:LN USD 20.22B 693M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Clovis Oncology CLVS:US USD 102.21M 40.07M
Enanta Pharmaceuticals ENTA:US USD 311.71M 1.32M
Esperion Therapeutics ESPR:US USD 261.78M 9.31M
Halozyme Therapeutics HALO:US USD 653.2M 111.26M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Insmed INSM:US USD 632.16M 42.56M
Intercept Pharmaceuticals ICPT:US USD 545.37M 58.36M
Lexicon Pharmaceuticals LXRX:US USD 139.06M 74.16M
Ligand Pharmaceuticals LGND:US USD 220.43M 23.35M
Minerva Neurosciences NERV:US USD 44.84M 5.2M
Moderna Inc MRNA:US USD 14.3B 734M
Novartis NVS:US USD 36.91B 44M
Ptc Therapeutics PTCT:US USD 517.26M 177.41M
Puma Biotechnology PBYI:US USD 122.35M 8.07M
Sangamo Biosciences SGMO:US USD 336.62M 6.5M
Takeda 4502:JP JPY 2.6T 149.67B
Teva Pharmaceutical TEVA:IT USD 11.45B 711M
Ultragenyx Pharmaceutical RARE:US USD 1.01B 334.13M
Vanda Pharmaceuticals VNDA:US USD 507.11M 10.21M
Veracyte VCYT:US USD 238.52M 3.47M